Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 5592  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Ahead Of print
 ::  Search Pubmed for
 
    -  Tripathi R K
    -  Shah A
    -  Jalgaonkar S V
    -  Kerkar S
 :: Article in PDF

  IN THIS Article
 ::  Abstract

 Article Access Statistics
    Viewed355    
    PDF Downloaded20    

Recommend this journal


 

Previous Article  Table of Contents   Next Article  
ORIGINAL ARTICLE
Ahead of print publication

Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management


1 Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra, India
2 Department of Ophthalmology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra, India

Date of Submission20-Nov-2022
Date of Decision22-Jan-2023
Date of Acceptance20-Feb-2023
Date of Web Publication13-Jun-2023

Correspondence Address:
RK Tripathi,
Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jpgm.jpgm_905_22

PMID: 37313943


 :: Abstract 


Introduction: Primary open angle glaucoma (POAG) treatment is characterized by long-duration therapy, prescription variability, and non-adherence. Patient awareness toward drug treatment is crucial to ensure adherence. The present study was planned to evaluate drug treatment awareness, patient-perceived drug adherence, and prescription patterns in POAG patients.
Methodology: This was a cross-sectional, single-center, questionnaire-based study conducted in the ophthalmology out patient department of a tertiary care hospital from April 2020 to November 2021. Patients of either gender, aged 40–70 years, with a confirmed diagnosis of POAG, who had records of POAG medications for at least last 3 months and who provided written informed consent, were included. Prescription details were recorded, and subsequently, patients were administered a pre-validated drug treatment awareness (14 items) questionnaire, a self-reported medication adherence (9-item) questionnaire, and then they performed eye drop instillation in a simulated setting.
Results: The total number of patients enrolled was 180, which yielded 200 prescriptions. The mean drug treatment awareness score was 8.18 ± 3.30, and 135 (75%) patients scored more than 50% (≥7/14). Similarly, 159 patients (83.33%) had scored >50% (i.e. >5/9), with a mean score of 6.30 ± 1.70 in the medication treatment adherence questionnaire. The mean eye drop instillation performance score was 7.18 ± 1.20. The 200 POAG prescriptions containing 306 drugs were analyzed, with beta blockers (184/200, 92%) and timolol (168/200, 84% encounters) being the highest prescribed classes/drugs.
Conclusion: POAG patients did have adequate treatment awareness with good self-reported medication adherence and performance of eye drop instillation technique. Around 25% patients lacked awareness; hence, reinforcement education programs on medication regimens need to be implemented.


Keywords: Antiglaucoma drugs, eye drop, POAG, prescription variability, questionnaire, timolol



How to cite this URL:
Tripathi R K, Shah A, Jalgaonkar S V, Kerkar S. Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management. J Postgrad Med [Epub ahead of print] [cited 2023 Sep 26]. Available from: https://www.jpgmonline.com/preprintarticle.asp?id=378430


.




 

Top
 
Previous Article  Next Article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow